Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 1,412 | 1,456 | 1,279 | 1,677 | 1,313 |
| Gross Profit | 1,412 | 1,456 | 1,279 | 1,677 | 1,313 |
| Operating Expenses | 5,312 | 5,255 | 4,976 | 4,976 | 5,171 |
| Operating Income | -3,900 | -3,799 | -3,697 | -3,299 | -3,858 |
| Interest Expense | 57 | 61 | 27 | 34 | 62 |
| Other Income | 54 | 986 | 784 | 72 | 110 |
| Pre-tax Income | -3,903 | -2,874 | -2,940 | -3,261 | -3,810 |
| Net Income Continuous | -3,903 | -2,874 | -2,940 | -3,261 | -3,810 |
| Net Income | $-3,903 | $-2,874 | $-2,940 | $-3,261 | $-3,810 |
| EPS Basic Total Ops | -9.50 | -9.25 | -11.25 | -18.75 | -14.50 |
| EPS Basic Continuous Ops | -9.55 | -9.15 | -11.31 | -18.86 | -14.49 |
| EPS Diluted Total Ops | -12.75 | -9.25 | -17.75 | -18.75 | -14.50 |
| EPS Diluted Continuous Ops | -7.28 | -9.15 | -6.84 | -18.86 | -14.49 |
| EPS Diluted Before Non-Recurring Items | -16.75 | -11.50 | -17.75 | N/A | N/A |
| EBITDA(a) | $-3,572 | $-3,600 | $-3,523 | $-3,128 | $-3,677 |